Humanigen seeks EUA from USFDA for Lenzilumab to treat COVID-19 EP News Bureau May 30, 2021 This EUA application follows positive results from the LIVE-AIR Phase 3 clinical trial evaluating the ability of lenzilumab to…
Humanigen, EVERSANA to partner for launch, commercialisation of Lenzilumab for COVID-19 treatment EP News Bureau Jan 10, 2021 Lenzilumab, a monoclonal antibody, is designed to prevent and treat cytokine storm, a complication considered to be a leading…
Humanigen announces positive interim data of Lenzilumab in hospitalised COVID-19 patients EP News Bureau Nov 7, 2020 The company intends to file for EUA in the first quarter of 2021 either following interim data at 75 per cent or at study…
